Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123145892 | 12314589 | 2 | F | 20160404 | 20160909 | 20160428 | 20160914 | EXP | JP-GLAXOSMITHKLINE-JP2016JPN048617 | GLAXOSMITHKLINE | 78.49 | YR | F | Y | 36.00000 | KG | 20160914 | CN | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123145892 | 12314589 | 1 | PS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | 5 DF, BID | Y | N | 21077 | 5 | DF | INHALATION POWDER | BID | ||||
| 123145892 | 12314589 | 2 | SS | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | Y | N | 21077 | INHALATION POWDER | |||||||
| 123145892 | 12314589 | 3 | C | MADOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | 3 DF, 1D | 0 | 3 | DF | QD | ||||||||
| 123145892 | 12314589 | 4 | C | MIRAPEX-LA | 2 | 0.375 MG, QD | 0 | .375 | MG | QD | |||||||||
| 123145892 | 12314589 | 5 | C | MAGLAX | MAGNESIUM OXIDE | 1 | 660 MG, TID | 0 | 660 | MG | TID | ||||||||
| 123145892 | 12314589 | 6 | C | FP (JAPAN) | 2 | 2.5 MG, BID | 0 | 2.5 | MG | BID | |||||||||
| 123145892 | 12314589 | 7 | C | DONEPEZIL HYDROCHLORIDE. | DONEPEZIL HYDROCHLORIDE | 1 | 5 MG, QD | 0 | 5 | MG | QD | ||||||||
| 123145892 | 12314589 | 8 | C | AMBROXOL HYDROCHLORIDE | AMBROXOL HYDROCHLORIDE | 1 | 1 DF, TID | 0 | 1 | DF | TID | ||||||||
| 123145892 | 12314589 | 9 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | 1 ?G, QD | 0 | 1 | UG | QD | ||||||||
| 123145892 | 12314589 | 10 | C | CALBLOCK | AZELNIDIPINE | 1 | 8 MG, QD | 0 | 8 | MG | QD | ||||||||
| 123145892 | 12314589 | 11 | C | PRANLUKAST | PRANLUKAST | 1 | 225 MG, BID | 0 | 225 | MG | BID | ||||||||
| 123145892 | 12314589 | 12 | C | THEO-DUR | THEOPHYLLINE ANHYDROUS | 1 | 200 MG, BID | 0 | 200 | MG | BID | ||||||||
| 123145892 | 12314589 | 13 | C | KLARICID | CLARITHROMYCIN | 1 | 200 MG, BID | 0 | 200 | MG | BID | ||||||||
| 123145892 | 12314589 | 14 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | 500 MG, TID | 0 | 500 | MG | TID | ||||||||
| 123145892 | 12314589 | 15 | C | PREDONINE TABLETS | 2 | 20 MG, QD | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123145892 | 12314589 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123145892 | 12314589 | HO |
| 123145892 | 12314589 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123145892 | 12314589 | Decreased appetite | |
| 123145892 | 12314589 | Gait disturbance | |
| 123145892 | 12314589 | Hypokalaemia | |
| 123145892 | 12314589 | Hypotension | |
| 123145892 | 12314589 | Nausea | |
| 123145892 | 12314589 | Overdose | |
| 123145892 | 12314589 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123145892 | 12314589 | 1 | 20160404 | 20160410 | 0 | |
| 123145892 | 12314589 | 2 | 20160414 | 0 | ||
| 123145892 | 12314589 | 10 | 20160411 | 0 |